S100A9 Aggravates Cardiac Fibrosis by TLR4/PGC‐1α Mediated Macrophage‐Myofibroblast Crosstalk
Journal of Extracellular Vesicles · 2026-07 · 15 (7)
DOI: 10.1002/jev2.70338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 23.07.2026. Verfasst von Yiting Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of Chin…. Hauptthemen laut MEDLINE: Macrophages, Calgranulin B, Myofibroblasts, Toll-Like Receptor 4. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Anhui Provincial Natural Science Foundation, Talent Introduction Initiation Project of the First Affiliated Hospital of USTC.
Abstract (Originalsprache)
Fibrosis is a critical component of ventricular remodelling after myocardial ischemia, and the activation and expansion of cardiac fibroblasts represent key drivers of this process. Our previous work identified S100A9‐dependent macrophage‐to‐myofibroblast transition (MMT) as a newly recognized source of myofibroblasts in the post‐MIR heart. However, the mechanisms by which S100A9 regulates MMT remain incompletely understood. Here, using multiple genetically engineered mouse models, MIR and MI model, and in vitro multicellular co‐culture systems, we investigated the role of S100A9 in regulating fibroblast‐derived migrasome release during MMT. We found that macrophage‐derived S100A9 promotes mitochondrial dysfunction and migrasome release in cardiac fibroblasts through TLR4/PGC1α signalling following MIR. These fibroblast‐derived migrasomes, in turn, activate integrin/Src signalling in macrophages, triggering MMT and accelerating cardiac fibrosis. Importantly, we delineate how macrophage‐derived S100A9 orchestrates crosstalk between fibroblasts and immune cells and identify migrasome‐mediated activation of MMT as a previously unrecognized mechanism driving post‐MIR fibrotic remodelling. Our findings suggest that targeting S100A9‐induced migrasome release and downstream MMT signalling may represent a promising therapeutic strategy to mitigate pathological cardiac fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
- Department of Cardiology, The second Affiliated Hospital of Anhui medical university, Hefei, China.
- Department of Rheumatology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
- Department of Pediatrics, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Division of Life Sciences and Medicine, Department of Cardiac Surgery, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China.
ORCID-Profile: Shichun Shen
Förderung
- National Natural Science Foundation of China
- Anhui Provincial Natural Science Foundation
- Talent Introduction Initiation Project of the First Affiliated Hospital of USTC
- Science and Technology Rising Star Cultivation Programme of the Second Affiliated Hospital of Anhui Medical University
- Natural Science Foundation of Anhui Province
Zitieren
APA
Zhao, Y., Zhang, Y., Yuan, Q., Fang, X., Sheng, J., Deng, Y., & Shen, S. (2026). S100A9 Aggravates Cardiac Fibrosis by TLR4/PGC‐1α Mediated Macrophage‐Myofibroblast Crosstalk. Journal of Extracellular Vesicles, 15(7). https://doi.org/10.1002/jev2.70338
Vancouver
Zhao Y, Zhang Y, Yuan Q, Fang X, Sheng J, Deng Y, et al. S100A9 Aggravates Cardiac Fibrosis by TLR4/PGC‐1α Mediated Macrophage‐Myofibroblast Crosstalk. Journal of Extracellular Vesicles. 2026;15(7). doi:10.1002/jev2.70338
BibTeX
@article{Zhao2026,
author = {Zhao, Yiting and Zhang, Yaqin and Yuan, Qiang and Fang, XiaoFeng and Sheng, Jianlong and Deng, Yuhang and Shen, Shichun},
title = {S100A9 Aggravates Cardiac Fibrosis by TLR4/PGC‐1α Mediated Macrophage‐Myofibroblast Crosstalk},
journal = {Journal of Extracellular Vesicles},
year = {2026},
volume = {15},
number = {7},
doi = {10.1002/jev2.70338}
}
EUVIMED